Soluble cytokine receptors and receptor antagonists are sequentially released after trauma

M Cinat1, K Waxman, N D Vaziri

  • 1Department of Surgery, University of California Irvine Medical Center, Orange 92668, USA.

Insights

Trauma patients show elevated levels of soluble tumor necrosis factor receptors (sTNF-R) upon emergency department arrival. This suggests a potential sequential release pattern of these receptors following traumatic injury.

Area of Science:

  • Immunology
  • Trauma Medicine
  • Biochemistry

Background:

  • Cytokine receptors and receptor antagonists (RAs) are implicated in trauma response.
  • The sequential release of cytokines after injury is a known phenomenon.
  • The dynamic changes in soluble cytokine receptors and RAs post-trauma require further investigation.

Purpose of the Study:

  • To investigate the hypothesis that soluble cytokine receptors and RAs are sequentially released after traumatic injury.
  • To quantify the levels of specific soluble cytokine receptors and RAs in trauma patients.
  • To compare these levels to healthy controls and analyze their dynamics over time.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) kits were used to measure levels of tumor necrosis factor (TNF), soluble TNF-receptors (sTNF-R) 55 kd and 75 kd, interleukin (IL)-1, IL-1 RA, IL-2, and IL-2r.
  • Sera were collected from 22 trauma patients on arrival and serially for up to 7 days.
  • Sera from 22 healthy individuals served as normal controls.

Main Results:

  • No detectable levels of TNF, IL-1, or IL-2 were found in patient sera post-injury.
  • Both 55 kd and 75 kd sTNF-R were significantly elevated in trauma patients upon emergency department arrival compared to controls (p < 0.001).
  • Elevated sTNF-R levels were 2,441 +/- 506 pg/mL for 55 kd and 4,736 +/- 537 pg/mL for 75 kd.

Conclusions:

  • Traumatic injury leads to a significant and immediate elevation of soluble TNF receptors.
  • The findings support the hypothesis of a sequential release of soluble cytokine receptors post-trauma.
  • Further research is warranted to explore the clinical implications of these early receptor changes in trauma care.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...